| JYSB1300244 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2013-10-28 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2015-01-22 | view |
| JYSZ0800001 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2008-01-25 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2008-12-22 | view |
| JYSB2000323 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
| JYSB1400075 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2014-04-21 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2014-10-27 | view |
| JXSS0900003 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Import Drug Application | 2009-02-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2010-03-11 | view |
| JTH2000219 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JYSB1700216 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2017-12-01 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-04-25 | view |
| JYSB1200178 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2012-07-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2013-08-27 | view |
| JYHZ0700037 | 格列美脲片 | glimepiride | Tablet | Chemical Drugs | License Renew | 2007-04-11 | Sanofi-aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2008-07-09 | view |
| JYSB2100068 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
| JYSZ1900022 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | License Renew | 2019-05-20 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-10-28 | view |
| JYSB1400045 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2014-03-18 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2014-08-27 | view |
| JYHB0800683 | 头孢噻肟钠 | cefotaxime sodium | Active ingredient | Chemical Drugs | Supplementary Application | 2008-11-05 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2010-04-23 | view |
| JTH2000215 | L-iso-Asp(28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JXSL1500034 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Import Drug Application | 2015-07-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2017-06-09 | view |
| JXSL0900002 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Import Drug Application | 2009-03-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2009-12-29 | view |
| JTH2100025 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2021-01-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-02-05 | view |
| JXSS1800004 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Import Drug Application | 2018-04-16 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2019-12-06 | view |
| JYSB2000322 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
| JYSB1400074 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2014-04-21 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2014-10-27 | view |
